Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Neurology|October 11, 2013
Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group reportJennie W Taylor, Eoin P Flanagan, Brian P O'Neill, et al.
British Journal of Haematology|June 8, 2017
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patientsEldad J Dann, Osnat Bairey, Rachel Bar-Shalom, et al.
Journal of Neuro-Oncology|October 7, 2020
Correction to: Serum microRNA is a biomarker for post-operative monitoring in gliomaAndrew Morokoff, Jordan Jones, Hong Nguyen, et al.
The Lancet. Oncology|July 8, 2015
Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-OncologyKhê Hoang-Xuan, Eric Bessell, Jacoline Bromberg, et al.
Journal of Neuro-Oncology|September 11, 2020
Serum microRNA is a biomarker for post-operative monitoring in gliomaAndrew Morokoff, Jordan Jones, Hong Nguyen, et al.
Blood|January 9, 2025
Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 studyMax S Topp, Matthew Matasar, John N Allan, et al.
Leukemia & Lymphoma|September 28, 2020
Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experienceYafit Segman, Elena Ribakovsky, Abraham Avigdor, et al.
The Lancet. Oncology|March 15, 2021
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 studyJohn Kuruvilla, Radhakrishnan Ramchandren, Armando Santoro, et al.
NAR Cancer|November 3, 2025
Brain tumor classification from FFPE samples using nanopore methylation sequencingGalina Feinberg-Gorenshtein, Assaf Grunwald, Carlo Vermeulen, et al.
Annals of Hematology|January 27, 2022
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysisIrit Avivi, Chava Perry, Yafit Segman, et al.
Pageof 15